Literature DB >> 25653246

Endocan and atherosclerosis.

Sevket Balta1, Dimitri P Mikhailidis2, Sait Demirkol3, Turgay Celik3, Cengiz Ozturk3, Atila Iyisoy3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25653246     DOI： 10.1177/0003319715568973

Source DB:  PubMed          Journal:  Angiology        ISSN： 0003-3197            Impact factor:   3.619


× No keyword cloud information.
  4 in total

1.  Endocan, Novel Potential Biomarker for Systemic Sclerosis: Results of a Pilot Study.

Authors:  Paul Bălănescu; Anca Lădaru; Eugenia Bălănescu; Theodor Voiosu; Cristian Băicuş; Gheorghe Andrei Dan
Journal:  J Clin Lab Anal       Date:  2015-09-01       Impact factor: 2.352

2.  The Relationship between Serum Endocan Levels and Depression in Alzheimer's Disease.

Authors:  Kyung Hee Yoon; So Yeon Kim; Yoo Sun Moon; Daeyoung Roh; Sang Kyu Lee; Do Hoon Kim
Journal:  Dis Markers       Date:  2016-01-26       Impact factor: 3.434

3.  Can Serum Endocan Levels be Used as an Early Prognostic Marker for Endothelial Dysfunction in COVID-19?

Authors:  Duygu Guzel; Emra Asfuroglu Kalkan; Funda Eren; Oguzhan Zengin; Ozcan Erel; Enes S Sahiner; Osman Inan; Ihsan Ates
Journal:  Angiology       Date:  2021-10-18       Impact factor: 3.619

4.  Endocan Measurement for Active Behçet Disease.

Authors:  Ayhan Kul; Orhan Ateş; Meltem Alkan Melikoğlu; Mahir Uğur; Nurinnisa Öztürk; Gülsüm Erkayhan; İbrahim Koçer
Journal:  Arch Rheumatol       Date:  2017-03-24       Impact factor: 1.472
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.